The Spot sign and Tranexamic acid on Preventing ICH growth- AUStralasia Trial
Lead PI: Prof Geoff Donnan & Prof Steve Davis
No. of Patients Currently Recruited: 100 No. of Patients Required: 100
STOP-AUST aims to test if intracerebral haemorrhage (ICH) patients who have contrast extravasation on computed tomography angiography, the ‘spot sign’, have lower rates of haematoma growth when treated with tranexamic acid within 4.5 hours of stroke onset, compared to placebo.